These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38267835)

  • 1. Spinal adhesive arachnoiditis in an adult patient with spinal muscular atrophy type 3 treated with intrathecal therapy.
    Ubysz J; Koszewicz M; Bladowska J; Budrewicz S
    BMC Neurol; 2024 Jan; 24(1):43. PubMed ID: 38267835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy.
    Mousa MA; Aria DJ; Schaefer CM; Kaye RD; Abruzzo TA; Bernes SM; Willard SD; Riemann MC; Towbin RB
    Pediatr Radiol; 2018 Nov; 48(12):1797-1805. PubMed ID: 30022258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fulminant adhesive arachnoiditis].
    Tomczykiewicz K; Stępień A; Staszewski J; Sadowska M; Bogusławska-Walecka R
    Neurol Neurochir Pol; 2012; 46(4):407-10. PubMed ID: 23023442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Complex Spine in Children with Spinal Muscular Atrophy: The Transforaminal Approach-A Transformative Technique.
    Towbin R; Schaefer C; Kaye R; Abruzzo T; Aria DJ
    AJNR Am J Neuroradiol; 2019 Aug; 40(8):1422-1426. PubMed ID: 31296522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Association Between Intrathecal Drug Administration and Arachnoiditis Ossificans.
    Ward M; Mammis A; Barry MT; Heary RF
    World Neurosurg; 2018 Jul; 115():400-406. PubMed ID: 29747017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal adhesive arachnoiditis: three case reports and review of literature.
    Jurga S; Szymańska-Adamcewicz O; Wierzchołowski W; Pilchowska-Ujma E; Urbaniak Ł
    Acta Neurol Belg; 2021 Feb; 121(1):47-53. PubMed ID: 32833147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unilateral interlaminar fenestration on the convex side provides a reliable access for intrathecal administration of nusinersen in spinal muscular atrophy: a retrospective study.
    Wang Z; Feng E; Jiao Y; Zhao J; Chen X; Zhang H; Liang J; Li Z; Cui X; Chen W; Shen J
    Orphanet J Rare Dis; 2023 Nov; 18(1):369. PubMed ID: 38031122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Appearance of Advanced Chronic Adhesive Arachnoiditis: A Retrospective Review.
    Anderson TL; Morris JM; Wald JT; Kotsenas AL
    AJR Am J Roentgenol; 2017 Sep; 209(3):648-655. PubMed ID: 28639826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed-tomography-guided transforaminal intrathecal nusinersen injection in adults with spinal muscular atrophy type 2 and severe spinal deformity. Feasibility, safety and radiation exposure considerations.
    Spiliopoulos S; Reppas L; Zompola C; Palaiodimou L; Papadopoulou M; Filippiadis D; Palialexis K; Ploussi A; Efstathopoulos E; Tsivgoulis G; Brountzos E
    Eur J Neurol; 2020 Jul; 27(7):1343-1349. PubMed ID: 32250518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nusinersen Administration Via an Intrathecal Port in a 16-Year-Old Spinal Muscular Atrophy Patient with Profound Scoliosis.
    Flotats-Bastardas M; Linsler S; Zemlin M; Meyer S
    Pediatr Neurosurg; 2020; 55(1):54-57. PubMed ID: 31722365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy.
    Veerapandiyan A; Pal R; D'Ambrosio S; Young I; Eichinger K; Collins E; Westesson PL; Kwon J; Ciafaloni E
    Neurology; 2018 Aug; 91(7):e620-e624. PubMed ID: 30006410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lumbosacral ventral spinal nerve root atrophy identified on MRI in a case of spinal muscular atrophy type II.
    Smith G; Bell SK; Sladky JT; Kang PB; Albayram MS
    Clin Imaging; 2019; 53():134-137. PubMed ID: 30340076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study.
    Finkel RS; Chiriboga CA; Vajsar J; Day JW; Montes J; De Vivo DC; Yamashita M; Rigo F; Hung G; Schneider E; Norris DA; Xia S; Bennett CF; Bishop KM
    Lancet; 2016 Dec; 388(10063):3017-3026. PubMed ID: 27939059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound assisted lumbar intrathecal administration of nusinersen in adult patients with spinal muscular atrophy: A case series.
    Zanfini BA; Catarci S; Patanella AK; Pane M; Frassanito L; Filipponi E; Mercuri E; Sabatelli M; Draisci G
    Muscle Nerve; 2021 Nov; 64(5):594-599. PubMed ID: 34396547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic lumbar spinal arachnoiditis: fact or fallacy?
    Petty PG; Hudgson P; Hare WS
    J Clin Neurosci; 2000 Sep; 7(5):395-9. PubMed ID: 10942659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Intrathecal Ossification in Arachnoiditis Ossificans: A Retrospective Case Series.
    Thejeel B; Geannette CS; Roytman M; Pisapia DJ; Chazen JL; Jawetz ST
    AJNR Am J Neuroradiol; 2023 Feb; 44(2):228-234. PubMed ID: 36635055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.
    Walter MC; Wenninger S; Thiele S; Stauber J; Hiebeler M; Greckl E; Stahl K; Pechmann A; Lochmüller H; Kirschner J; Schoser B
    J Neuromuscul Dis; 2019; 6(4):453-465. PubMed ID: 31594243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript "single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1" written by pechmann and colleagues".
    Sansone VA; Pane M; Messina S; Bruno C; D'Amico A; Albamonte E; Catteruccia M; Sframeli M; Pedemonte M; Vita G; Bertini E; Mercuri E;
    Eur J Paediatr Neurol; 2018 Jul; 22(4):729-731. PubMed ID: 29673809
    [No Abstract]   [Full Text] [Related]  

  • 19. Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis.
    Gauthier-Loiselle M; Cloutier M; Toro W; Patel A; Shi S; Davidson M; Bischof M; LaMarca N; Dabbous O
    Adv Ther; 2021 Dec; 38(12):5809-5828. PubMed ID: 34713391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis.
    Fox D; To TM; Seetasith A; Patel AM; Iannaccone ST
    Adv Ther; 2023 Mar; 40(3):903-919. PubMed ID: 36534265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.